We are live on ! Find out more
SC

Stralem & Co Portfolio holdings

AUM $157M
1-Year Est. Return 4.29%
This Fund
S&P 500
This Quarter Est. Return
+0.77%
1 Year Est. Return
+4.29%
3 Year Est. Return
+25.48%
5 Year Est. Return
+55.56%
10 Year Est. Return
–
AUM
$1.46B
AUM Growth
-$332M
Cap. Flow
-$346M
Cap. Flow %
-23.7%
Top 10 Hldgs %
32.19%
Holding
55
New
1
Increased
2
Reduced
39
Closed
1

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$39M
2
BMY icon
Bristol-Myers Squibb
BMY
+$3.84M
3
MDLZ icon
Mondelez International
MDLZ
+$298K

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$43.3M
2
SBUX icon
Starbucks
SBUX
+$17.9M
3
DD icon
DuPont de Nemours
DD
+$17.3M
4
GE icon
GE Aerospace
GE
+$15M
5
DIS icon
Walt Disney
DIS
+$14.5M

Sector Composition

Rank Sector Weight
1 Healthcare 26.94%
2 Energy 12.53%
3 Industrials 12.01%
4 Communication Services 11.98%
5 Utilities 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EOG icon
26
EOG Resources
EOG
$75.1B
$36.2M 2.48%
413,411
-75,189
-15% -$6.95M
GOOG icon
27
Alphabet (Google) Class C
GOOG
$4.19T
$36M 2.47%
1,334,360
-293,036
-18% -$7.85M
APA icon
28
APA Corp
APA
$14B
$35.4M 2.43%
614,093
-29,057
-5% -$1.83M
XOM icon
29
ExxonMobil
XOM
$657B
$35.3M 2.42%
424,675
-76,267
-15% -$6.56M
CVX icon
30
Chevron
CVX
$386B
$33.6M 2.3%
348,362
-53,561
-13% -$5.62M
ABT icon
31
Abbott
ABT
$192B
$33M 2.26%
671,625
-166,479
-20% -$7.99M
CELG
32
DELISTED
Celgene Corp
CELG
$31.3M 2.14%
270,224
-62,886
-19% -$7.19M
TMO icon
33
Thermo Fisher Scientific
TMO
$223B
$30.4M 2.09%
234,359
-53,091
-18% -$6.92M
AMGN icon
34
Amgen
AMGN
$225B
$29.9M 2.05%
194,718
-43,412
-18% -$6.95M
JNJ icon
35
Johnson & Johnson
JNJ
$629B
$28M 1.92%
287,306
-69,594
-19% -$6.97M
MDLZ icon
36
Mondelez International
MDLZ
$79.4B
$5.86M 0.4%
142,350
+7,600
+6% +$298K
BMY icon
37
Bristol-Myers Squibb
BMY
$130B
$5.79M 0.4%
87,000
+58,200
+202% +$3.84M
TE
38
DELISTED
TECO ENERGY INC
TE
$1.84M 0.13%
104,000
-176,200
-63% -$3.3M
ADP icon
39
Automatic Data Processing
ADP
$107B
$1.8M 0.12%
22,450
-400
-2% -$34.1K
FE icon
40
FirstEnergy
FE
$27.2B
$1.57M 0.11%
48,400
-1,200
-2% -$42K
UNP icon
41
Union Pacific
UNP
$174B
$1.19M 0.08%
12,500
– –
CL icon
42
Colgate-Palmolive
CL
$73.6B
$1.12M 0.08%
17,100
– –
A icon
43
Agilent Technologies
A
$41.9B
$1.11M 0.08%
28,800
-700
-2% -$29.1K
IFF icon
44
International Flavors & Fragrances
IFF
$21.4B
$1.05M 0.07%
9,600
– –
BRK.B icon
45
Berkshire Hathaway Class B
BRK.B
$1.09T
$1.02M 0.07%
7,500
– –
ZBH icon
46
Zimmer Biomet
ZBH
$18.7B
$1.02M 0.07%
9,631
– –
GILD icon
47
Gilead Sciences
GILD
$168B
$983K 0.07%
8,400
– –
PEP icon
48
PepsiCo
PEP
$189B
$681K 0.05%
7,300
– –
PG icon
49
Procter & Gamble
PG
$335B
$591K 0.04%
7,550
– –
ABBV icon
50
AbbVie
ABBV
$440B
$571K 0.04%
8,500
– –
1
2
3

Similar funds

LI
Leap Investments Chicago, Illinois $152M AUM 3.6% 1-Year Est. Return
BC
Blackstart Capital New York $151M AUM 14.01% 1-Year Est. Return
JT
Jump Trading Chicago, Illinois $150M AUM 17.61% 1-Year Est. Return
SCM
Stellar Capital Management Phoenix, Arizona $147M AUM 5.91% 1-Year Est. Return
HF
Hellman & Friedman San Francisco, California $169M AUM
SMFS
Squar Milner Financial Services Irvine, California $176M AUM 10.56% 1-Year Est. Return
CCM
Cloverdale Capital Management Dallas, Texas $135M AUM 13.89% 1-Year Est. Return
CCM
Castine Capital Management Boston, Massachusetts $129M AUM 23.45% 1-Year Est. Return

Stralem & Co's Q2 2015 Portfolio in Review

As of Q2 2015, Stralem & Co held 55 positions worth $1.46B, down 19% from $1.79B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Stralem & Co withdrew a net $346M in Q2 2015, closing 1 position and reducing 39 holdings. Its most notable exit was Qualcomm, an estimated $43.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 27% a quarter earlier, followed by Energy and Industrials.

Against the trend, Stralem & Co opened a new position in Adobe worth $40.5M.

  • Stralem & Co's largest Q2 2015 buy was Adobe: 500,068 shares worth $40.5M.
  • Stralem & Co added most to Bristol-Myers Squibb in Q2 2015, an estimated $3.84M increase.
  • Stralem & Co's biggest Q2 2015 reduction was Starbucks, cutting an estimated $17.9M.
  • Stralem & Co fully exited Qualcomm in Q2 2015, selling an estimated $43.3M.
  • Stralem & Co's ten largest holdings make up 32% of its $1.46B portfolio in Q2 2015.
  • Stralem & Co opened 1 new position and closed 1 in Q2 2015.
  • Stralem & Co's portfolio value fell 19% quarter-over-quarter to $1.46B.

Based on Stralem & Co's 13F filing for Q2 2015, filed 16 Jul 2015.